Koyuncu, M. B. Et Al. 2022. Ruxolitinib Reduces Oxidative Stress in Patients With Primary Myelofibrosis: A Multicenter Study.. Cureus , vol.14, no.1 .

Koyuncu, M. B., Ilgan, M., Basir, H., Tombak, A., Ucar, M. A., Koseci, T., ... Akdeniz, A.(2022). Ruxolitinib Reduces Oxidative Stress in Patients With Primary Myelofibrosis: A Multicenter Study.. Cureus , vol.14, no.1.

Koyuncu, Mahmut Et Al. "Ruxolitinib Reduces Oxidative Stress in Patients With Primary Myelofibrosis: A Multicenter Study.," Cureus , vol.14, no.1, 2022

Koyuncu, Mahmut B. Et Al. "Ruxolitinib Reduces Oxidative Stress in Patients With Primary Myelofibrosis: A Multicenter Study.." Cureus , vol.14, no.1, 2022

Koyuncu, M. B. Et Al. (2022) . "Ruxolitinib Reduces Oxidative Stress in Patients With Primary Myelofibrosis: A Multicenter Study.." Cureus , vol.14, no.1.

@article{article, author={Mahmut B Koyuncu Et Al. }, title={Ruxolitinib Reduces Oxidative Stress in Patients With Primary Myelofibrosis: A Multicenter Study.}, journal={Cureus}, year=2022}